{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:43:49Z","timestamp":1778327029516,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"am","delay-in-days":286,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.ejso.2024.108468","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:06:40Z","timestamp":1717582000000},"page":"108468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1\/2 dose escalation and expansion trial"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2840-8206","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Dumont","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9885-8600","authenticated-orcid":false,"given":"Vahan","family":"Kepenekian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Passot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-C\u00e9cile","family":"Ezanno-Manasterski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4793-0008","authenticated-orcid":false,"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6305-8953","authenticated-orcid":false,"given":"Jean-Luc","family":"Raoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4014-4028","authenticated-orcid":false,"given":"B\u00e9n\u00e9dicte","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3789-8171","authenticated-orcid":false,"given":"Sandrine","family":"Hiret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"Senellart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Pein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Raimbourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loic","family":"Campion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Thibaudeau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1925-6921","authenticated-orcid":false,"given":"Julie","family":"Paul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2802-4974","authenticated-orcid":false,"given":"Olivier","family":"Glehen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejso.2024.108468_bib1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"10.1016\/j.ejso.2024.108468_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/DCR.0000000000000412","article-title":"Epidemiology, Management, and survival of peritoneal carcinomatosis from colorectal cancer: a population-based study","volume":"58","author":"Quere","year":"2015","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2024.108468_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12885-015-1081-8","article-title":"Incidence, time course and independent risk factors for metachronous peritoneal carcinomatosis of gastric origin--a longitudinal experience from a prospectively collected database of 1108 patients","volume":"15","author":"Seyfried","year":"2015","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.108468_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","article-title":"Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841","volume":"20","author":"Franko","year":"2012","journal-title":"J Clin Oncol. January"},{"issue":"3","key":"10.1016\/j.ejso.2024.108468_bib5","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/ijc.28373","article-title":"Peritoneal carcinomatosis of gastric origin: a population-based study on incidence, survival and risk factors","volume":"134","author":"Thomassen","year":"2014","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2024.108468_bib6","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/S1470-2045(19)30318-3","article-title":"Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications","volume":"20","author":"Alyami","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2024.108468_bib7","article-title":"Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","author":"Alyami","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2024.108468_bib8","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1245\/s10434-020-09558-4","article-title":"Pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase II trial (CRC-PIPAC)","volume":"28","author":"Rovers","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108468_bib9","first-page":"193","article-title":"A phase I dose-escalation of oxaliplatin delivered via a laparoscopic approach using pressurised intraperitoneal aerosol chemotherapy for advanced peritoneal metastases of gastrointestinal tract cancers","volume":"138","author":"Dumont","year":"2020","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2024.108468_bib10","doi-asserted-by":"crossref","DOI":"10.1515\/pp-2018-0120","volume":"3","author":"Dumont","year":"2018","journal-title":"Pleura Peritoneum"},{"issue":"2","key":"10.1016\/j.ejso.2024.108468_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108468_bib12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2016-0011","article-title":"Peritoneal sampling and histological assessment of therapeutic response in peritoneal metastasis: proposal of the Peritoneal Regression Grading Score (PRGS)","volume":"1","author":"Solass","year":"2016","journal-title":"Pleura Peritoneum"},{"issue":"14","key":"10.1016\/j.ejso.2024.108468_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12957-016-0892-7","article-title":"Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis","author":"Robella","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108468_bib14","doi-asserted-by":"crossref","first-page":"7814","DOI":"10.1245\/s10434-023-13941-2","article-title":"Safety and efficacy of oxaliplatin pressurized intraperitoneal aerosolized chemotherapy (PIPAC) in colorectal and appendiceal cancer with peritoneal metastases: results of a multicenter phase I trial in the USA","volume":"30","author":"Raoof","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108468_bib15","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-20-2152","article-title":"PIPAC-OX: a phase I study of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with peritoneal metastases","volume":"27","author":"Kim","year":"2021","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.ejso.2024.108468_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1245\/s10434-007-9581-7","article-title":"Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure","volume":"15","author":"Boige","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108468_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/pp-2021-0126","article-title":"Acute respiratory distress syndrome (ARDS) after pressurized intraperitoneal aerosol chemotherapy with oxaliplatin: a case report","volume":"6","author":"Thibaudeau","year":"2021","journal-title":"Pleura and Peritoneum"},{"issue":"8","key":"10.1016\/j.ejso.2024.108468_bib18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(14)70227-X","article-title":"Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial","volume":"15","author":"Taieb","year":"2014","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108468_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1515\/pp-2022-0118","article-title":"Peritoneal regression grading score (PRGS) in peritoneal metastasis: how many biopsies should be examined?","volume":"7","author":"Solass","year":"2022","journal-title":"Pleura and Peritoneum"},{"issue":"2","key":"10.1016\/j.ejso.2024.108468_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/pp-2023-0014","article-title":"Peritoneal regression grading score (PRGS): first evidence for independent predictive and prognostic significance","volume":"8","author":"Baake","year":"2023","journal-title":"Pleura and Peritoneum"},{"issue":"10","key":"10.1016\/j.ejso.2024.108468_bib21","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/jjco\/hyu114","article-title":"Enhancing the objectivity of the Japanese classification of peritoneal metastases from colorectal cancer","volume":"44","author":"Kobayashi","year":"2014","journal-title":"Jpn J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108468_bib22","first-page":"237","article-title":"Effect of cis-diammino-dichloro-platinum (II) on cell growth and cell cycle progression of a mouse ascites tumor growing in vivo","volume":"3","author":"Lewin","year":"1989","journal-title":"In Vivo"},{"issue":"1","key":"10.1016\/j.ejso.2024.108468_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2017.07.084","article-title":"Organoids as preclinical models to improve intraperitoneal chemotherapy effectiveness for colorectal cancer patients with peritoneal metastases: preclinical models to improve HIPEC","volume":"531","author":"Roy","year":"2017","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.ejso.2024.108468_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/02656736.2019.1704891","article-title":"PIPAC versus HIPEC: cisplatin spatial distribution and diffusion in a swine model","volume":"37","author":"Davigo","year":"2020","journal-title":"Int J Hyperthermia"},{"issue":"3","key":"10.1016\/j.ejso.2024.108468_bib25","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11523-015-0400-y","article-title":"A review of clinical studies and practical guide for the administration of triplet chemotherapy regimens with bevacizumab in first-line metastatic colorectal cancer","volume":"11","author":"Loupakis","year":"2016","journal-title":"Targ Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108468_bib26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/annonc\/mdu580","article-title":"Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial","volume":"26","author":"Gruenberger","year":"2015","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2024.108468_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamasurg.2019.1694","article-title":"Role of hepatic artery infusion chemotherapy in treatment of initially unresectable colorectal liver metastases: a review","volume":"154","author":"Datta","year":"2019","journal-title":"JAMA Surg"},{"issue":"17","key":"10.1016\/j.ejso.2024.108468_bib28","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1403108","article-title":"Initial therapy with FOLFOXIRI and bevacizumab for metastatic colorectal cancer","volume":"371","author":"Loupakis","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ejso.2024.108468_bib29","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1470-2045(15)00553-7","article-title":"Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial","volume":"17","author":"Fujitani","year":"2016","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108468_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/AS9.0000000000000203","article-title":"Treatment response after pressurized IntraPeritoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of colorectal originf","volume":"3","author":"H\u00fcbner","year":"2022","journal-title":"Ann Surg Open"},{"issue":"1","key":"10.1016\/j.ejso.2024.108468_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep18632","article-title":"Systemic treatment of patients with metachronous peritoneal carcinomatosis of colorectal origin","volume":"5","author":"van Oudheusden","year":"2016","journal-title":"Sci Rep"},{"issue":"9863","key":"10.1016\/j.ejso.2024.108468_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(12)61900-X","article-title":"Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"26","author":"Grothey","year":"2013","journal-title":"Lancet. January"},{"issue":"20","key":"10.1016\/j.ejso.2024.108468_bib33","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1414325","article-title":"Randomized trial of TAS-102 for refractory metastatic colorectal cancer","volume":"372","author":"Mayer","year":"2015","journal-title":"N Engl J Med. May 14"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324005201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324005201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T19:20:04Z","timestamp":1737314404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324005201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S0748798324005201"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108468","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIPAC in patients with peritoneal metastases from gastrointestinal tract (PIPOX01): An open label, non-comparative phase 1\/2 dose escalation and expansion trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108468"}}